Cultivation of circulating tumor cells in esophageal cancer

Folia Histochemica et Cytobiologica

Volumn 52, Issue 3, 2014, Pages 171-177

  Bobek, Vladimir ^a,c   Matkowski, Rafal ^b   Gürlich, Robert ^a   Grabowski, Krzysztof ^b   Szelachowska, Jolanta ^b   Lischke, Robert ^c   Schützner, Jan ^c   Harustiak, Tomas ^c   Pazdro, Alexandr ^c   Rzechonek, Adam ^b   Kolostova, Katarina ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Circulating tumor cells; CTCs culture; Esophageal cancer; Gastrointestinal tumors; MetaCell

Indexed keywords

FLUORESCENT DYE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CELL ISOLATION; CELL SEPARATION; CELL STRUCTURE; CELL VIABILITY; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENRICHMENT CULTURE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PATIENT CARE; TUMOR CELL CULTURE; VITAL STAIN; ADENOCARCINOMA; BLOOD; CARCINOMA, SQUAMOUS CELL; CELL COUNT; ESOPHAGEAL NEOPLASMS; FILTRATION; PATHOLOGY; PROSPECTIVE STUDY; STAINING; TUMOR EMBOLISM;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CELL COUNT; ESOPHAGEAL NEOPLASMS; FILTRATION; HUMANS; NEOPLASTIC CELLS, CIRCULATING; PROSPECTIVE STUDIES; STAINING AND LABELING;

EID: 84907738688     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2014.0020     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.
2. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–2252.
3. Katayama A, Mafune K, Tanaka Y et al. Autopsy findings in patients after curative esophagectomy for esophageal carcinoma. J Am Coll Surg. 2003;196:866–873.
4. Elshimali YI, Grody WW. The clinical significance of circulating tumor cells in the peripheral blood. Diagn Molec Pathol. 2006;15:187–194.
5. Matsusaka S, Chìn K, Ogura M et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci. 2010;101:1067–1071.
6. Steinert G, Schölch S, Koch M, Weitz J. Biology and significance of circulating and disseminated tumour cells in colorectal cancer. Langenbecks Arch Surg. 2012;397:535–542.
7. Doyen J, Alix-Panabières C, Hofman P et al. Circulating tumor cells in prostate cancer: a potential surrogate marker of survival. Crit Rev Oncol Hematol. 2012;81:241–256.
8. Serrano MJ, Rovira PS, Martínez-Zubiaurre I, Rodriguez MD, Fernández M, Lorente JA. Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy. Exp Ther Med. 2012;4:43–48.
9. Eliasova P, Kolostova K, Kobierzycki C, Bobek V. Clinical studies monitoring circulating and disseminated tumor cells in gastrointestinal cancers. Folia Histochem Cytobiol. 2013;51:265–277.
10. Liu Z, Jiang M, Zhao J, Ju H. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res. 2007;10: 2992–2997.
11. Lurje G, Schiesser M, Claudius A, Schneider PM. Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. J Oncol. 2010;2010:392–652.
12. Vallböhmer D, Brabender J, Metzger R, Hölscher AH. Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors. J Gastrointest Surg. 2010;14(Suppl 1):75–80.
13. Huang P, Wang J, Guo Y et al. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer. J Cancer Res Clin Oncol. 2003;129:192–198.
14. Ikoma D, Ichikawa D, Ueda Y et al. Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer. Anticancer Res. 2007;27:535–539.
15. Ito H, Kanda T, Nishimaki T et al. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction. J Exp Clin Cancer Res. 2004;23:455–464.
16. Kaganoi J, Shimada Y, Kano M et al. Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis. Br J Surg. 2004;91:1055–1060.
17. Koike M, Hibi K, Kasai Y et al. Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood. Clin Cancer Res. 2002;8:2879–2882.
18. Nakashima S, Natsugoe S, Matsumoto M et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Surgery. 2003;133:162–169.
19. Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 2009;69:7135.
20. Armstrong AJ, Marengo MS, Oltean S et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res. 2011;9:997–1007.
21. Mego M, Mani SA, Cristofanilli M. Molecular mechanisms of metastasis in breast cancer — clinical applications. Nat Rev Clin Oncol. 2010;7:693–701.
22. Morgan TM, Lange PH, Vessella RL. Detection and characterization of circulating and disseminated prostate cancer cells. Front Biosci. 2007;12:3000–3009.
23. Ausch C, Dandachi N, Buxhofer-Ausch V et al. Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer. Clin Chem Lab Med. 2007;45: 351–356.
24. Nagrath S, Sequist LV, Maheswaran S et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007;450:1235–1239.
25. Fehm T, Müller V, Aktas B et al. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res Treat. 2010;124:403–412.
26. Flores LM, Kindelberger DW, Ligon AH et al. Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer. Br J Cancer. 2010;102:1495–1502.